Ischaemic Stroke – Current aspects concerning prevention: We need to act
Autor(a) principal: | |
---|---|
Data de Publicação: | 2004 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://revista.spmi.pt/index.php/rpmi/article/view/1748 |
Resumo: | Stroke is the main cause of morbidity and mortality in Portugal. Modern Medicine is contributing to increase the mean age of the population and consequently, the numbers of patients with stroke. Thrombolysis, recently approved in Europe, benefits only a minority of patients. Thus, we consider that the only form of reducing the incidence of this disease is by controlling risk factors. In this article we emphasize the importance of primary prevention and review risk factors most strongly related to stroke, with special attention to the controllable ones, namely hypertension and dyslipidemia, among others. Recent trials that clarify the role of statins and ACE-inhibitors in primary and secondary stroke prevention are reviewed. The importance of a healthy doctor-patient relationship, as well as the need for global information strategies, are underlined as the fundamental means to achieve patient compliance with the preventive measures proposed. |
id |
RCAP_b8422d1efc175897d1a0b114a6bb243e |
---|---|
oai_identifier_str |
oai:oai.revista.spmi.pt:article/1748 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Ischaemic Stroke – Current aspects concerning prevention: We need to actAcidente vascular cerebral isquémico – Prevenção: Aspectos actuais – É preciso agirAcidente Vascular Cerebralprevençãofactores de riscohipertensão arteriallipidosantiagregação plaquetáriaestatinasInibidores da ECAstrokerisk factorshypertensionlipidsstatinsACE-inhibitorsanti-platelet aggregationStroke is the main cause of morbidity and mortality in Portugal. Modern Medicine is contributing to increase the mean age of the population and consequently, the numbers of patients with stroke. Thrombolysis, recently approved in Europe, benefits only a minority of patients. Thus, we consider that the only form of reducing the incidence of this disease is by controlling risk factors. In this article we emphasize the importance of primary prevention and review risk factors most strongly related to stroke, with special attention to the controllable ones, namely hypertension and dyslipidemia, among others. Recent trials that clarify the role of statins and ACE-inhibitors in primary and secondary stroke prevention are reviewed. The importance of a healthy doctor-patient relationship, as well as the need for global information strategies, are underlined as the fundamental means to achieve patient compliance with the preventive measures proposed.O Acidente Vascular Cerebral (AVC) é a patologia com maior mortalidade e morbilidade em Portugal. A Medicina moderna tem contribuído para um aumento da população idosa e, consequentemente, aumento do número de doentes com AVC. A trombólise, recentemente aprovada na Europa, apenas beneficia um número muito restrito de doentes. Assim, consideramos que a única forma de tentar diminuir a incidência desta doença consiste no controlo dos factores de risco. Neste artigo salienta-se a importância da terapêutica preventiva, abordam-se os factores de risco mais frequentemente relacionados com o AVC, com especial ênfase para aqueles que podem ser controlados, nomeadamente a hipertensão arterial e a dislipidemia, entre outros. Abordam-se os novos estudos que clarificam o papel das estatinas e dos inibidores do enzima conversor da angiotensina na prevenção primária e secundária do AVC. Chama-se a atenção para a empatia necessária entre médico-doente para uma melhor aderência às medidas preventivas propostas. Salienta-se a importância de campanhas globais de informação como medida fundamental na diminuição da incidência do AVC.Sociedade Portuguesa de Medicina Interna2004-06-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://revista.spmi.pt/index.php/rpmi/article/view/1748Internal Medicine; Vol. 11 No. 2 (2004): Abril/ Junho; 99-108Medicina Interna; Vol. 11 N.º 2 (2004): Abril/ Junho; 99-1082183-99800872-671Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spmi.pt/index.php/rpmi/article/view/1748https://revista.spmi.pt/index.php/rpmi/article/view/1748/1210Silva, Franciscoinfo:eu-repo/semantics/openAccess2023-04-01T06:11:34Zoai:oai.revista.spmi.pt:article/1748Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:48:17.064844Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Ischaemic Stroke – Current aspects concerning prevention: We need to act Acidente vascular cerebral isquémico – Prevenção: Aspectos actuais – É preciso agir |
title |
Ischaemic Stroke – Current aspects concerning prevention: We need to act |
spellingShingle |
Ischaemic Stroke – Current aspects concerning prevention: We need to act Silva, Francisco Acidente Vascular Cerebral prevenção factores de risco hipertensão arterial lipidos antiagregação plaquetária estatinas Inibidores da ECA stroke risk factors hypertension lipids statins ACE-inhibitors anti-platelet aggregation |
title_short |
Ischaemic Stroke – Current aspects concerning prevention: We need to act |
title_full |
Ischaemic Stroke – Current aspects concerning prevention: We need to act |
title_fullStr |
Ischaemic Stroke – Current aspects concerning prevention: We need to act |
title_full_unstemmed |
Ischaemic Stroke – Current aspects concerning prevention: We need to act |
title_sort |
Ischaemic Stroke – Current aspects concerning prevention: We need to act |
author |
Silva, Francisco |
author_facet |
Silva, Francisco |
author_role |
author |
dc.contributor.author.fl_str_mv |
Silva, Francisco |
dc.subject.por.fl_str_mv |
Acidente Vascular Cerebral prevenção factores de risco hipertensão arterial lipidos antiagregação plaquetária estatinas Inibidores da ECA stroke risk factors hypertension lipids statins ACE-inhibitors anti-platelet aggregation |
topic |
Acidente Vascular Cerebral prevenção factores de risco hipertensão arterial lipidos antiagregação plaquetária estatinas Inibidores da ECA stroke risk factors hypertension lipids statins ACE-inhibitors anti-platelet aggregation |
description |
Stroke is the main cause of morbidity and mortality in Portugal. Modern Medicine is contributing to increase the mean age of the population and consequently, the numbers of patients with stroke. Thrombolysis, recently approved in Europe, benefits only a minority of patients. Thus, we consider that the only form of reducing the incidence of this disease is by controlling risk factors. In this article we emphasize the importance of primary prevention and review risk factors most strongly related to stroke, with special attention to the controllable ones, namely hypertension and dyslipidemia, among others. Recent trials that clarify the role of statins and ACE-inhibitors in primary and secondary stroke prevention are reviewed. The importance of a healthy doctor-patient relationship, as well as the need for global information strategies, are underlined as the fundamental means to achieve patient compliance with the preventive measures proposed. |
publishDate |
2004 |
dc.date.none.fl_str_mv |
2004-06-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revista.spmi.pt/index.php/rpmi/article/view/1748 |
url |
https://revista.spmi.pt/index.php/rpmi/article/view/1748 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revista.spmi.pt/index.php/rpmi/article/view/1748 https://revista.spmi.pt/index.php/rpmi/article/view/1748/1210 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Medicina Interna |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Medicina Interna |
dc.source.none.fl_str_mv |
Internal Medicine; Vol. 11 No. 2 (2004): Abril/ Junho; 99-108 Medicina Interna; Vol. 11 N.º 2 (2004): Abril/ Junho; 99-108 2183-9980 0872-671X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131565874216960 |